HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Giovanni Pratesi Selected Research
Giovanni Pratesi Research Topics
Disease
9
Aneurysm (Aneurysms)
03/2024 - 03/2006
9
Abdominal Aortic Aneurysm
02/2024 - 11/2005
8
Thrombosis (Thrombus)
08/2020 - 11/2005
6
Endoleak
04/2020 - 10/2009
4
Ischemia
11/2023 - 03/2006
3
Rupture
03/2024 - 09/2006
3
Pathologic Constriction (Stenosis)
12/2023 - 10/2017
3
Infections
07/2013 - 09/2007
2
Stroke (Strokes)
04/2024 - 12/2018
2
Chronic Renal Insufficiency
04/2024 - 02/2024
2
Acute Kidney Injury (Acute Renal Failure)
02/2024 - 11/2023
2
Chronic Limb-Threatening Ischemia
11/2023 - 01/2012
2
Mitochondrial Diseases (Mitochondrial Disease)
06/2022 - 09/2021
2
Vascular Diseases (Vascular Disease)
07/2021 - 09/2005
2
Carotid Artery Diseases
11/2014 - 09/2007
2
Atherosclerosis
10/2013 - 11/2007
1
Fibrosis (Cirrhosis)
04/2024
1
Prolapse
01/2024
1
Cardiovascular Diseases (Cardiovascular Disease)
10/2023
1
Hemorrhage
10/2023
1
Thoracoabdominal Aortic Aneurysm
04/2023
1
Popliteal Artery Aneurysm
01/2023
1
Myocardial Infarction
06/2022
1
Reperfusion Injury
06/2022
1
Renal Insufficiency (Renal Failure)
11/2021
1
Vascular System Injuries
11/2021
1
Aortic Diseases
11/2021
1
Necrosis
09/2021
1
COVID-19
07/2021
1
Iliac Aneurysm
11/2018
1
Genetic Predisposition to Disease (Genetic Predisposition)
10/2013
1
Carotid Artery Injuries
07/2013
1
False Aneurysm (Pseudoaneurysm)
07/2013
1
Chronic Obstructive Pulmonary Disease (COPD)
01/2012
1
Myocardial Ischemia (Ischemic Heart Diseases)
01/2010
1
Peripheral Arterial Disease
11/2007
1
Hyperhomocysteinemia
02/2005
1
Dyslipidemias (Dyslipidemia)
02/2005
Drug/Important Bio-Agent (IBA)
3
Lipoprotein(a)
IBA
10/2013 - 02/2005
1
Pyridinolcarbamate (P23)
IBA
04/2024
1
indoxyl
IBA
04/2024
1
Carbon Dioxide
IBA
02/2024
1
Antioxidants
IBA
06/2022
1
3-nitrotyrosine
IBA
09/2021
1
salicylhydroxamic acid (SHAM)
IBA
09/2021
1
PPAR gamma
IBA
09/2021
1
Myostatin
IBA
09/2021
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
09/2021
1
Messenger RNA (mRNA)
IBA
09/2021
1
Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)
IBA
11/2014
1
Glucose (Dextrose)
FDA Link
Generic
10/2013
1
Lipids
IBA
10/2013
1
Apolipoproteins E (ApoE)
IBA
10/2013
1
Low Density Lipoprotein Receptor-Related Protein-5
IBA
10/2013
1
Matrix Metalloproteinases (MMPs)
IBA
01/2012
1
Transforming Growth Factor-beta Type I Receptor
IBA
01/2009
1
Angiotensin II
IBA
01/2009
1
Heparin (Liquaemin)
FDA Link
Generic
01/2008
1
plasma protein Z (protein Z)
IBA
11/2007
1
RNA (Ribonucleic Acid)
IBA
09/2007
1
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
03/2006
1
Homocysteine
IBA
11/2005
1
Plasminogen Activator Inhibitor 1
IBA
11/2005
1
Plasminogen Activators (Plasminogen Activator)
IBA
11/2005
Therapy/Procedure
14
Stents
01/2024 - 09/2006
9
Endovascular Aneurysm Repair
03/2024 - 01/2014
5
Surgical Amputation (Amputations)
11/2023 - 01/2008
5
Vascular Surgical Procedures
06/2022 - 09/2005
2
Carotid Endarterectomy
01/2024 - 07/2013
2
Endovascular Procedures
01/2020 - 07/2013
2
Ligation
08/2012 - 03/2006
2
Limb Salvage
01/2012 - 03/2006
1
Electrocoagulation (Electrocautery)
03/2024
1
Erythrocyte Transfusion
10/2023
1
Length of Stay
07/2021
1
Continuity of Patient Care
07/2021
1
Personal Protective Equipment
07/2021
1
Catheters
01/2020
1
Off-Label Use
11/2018
1
Prostheses and Implants (Prosthesis)
10/2017
1
Conversion to Open Surgery
01/2012
1
Perioperative Period
09/2006